secwatch / observer
8-K filed July 19, 2021, 7:59 PM ET ticker PLUR CIK 0001158780
leadership confidence high sentiment neutral materiality 0.50

Pluristem Therapeutics appoints Prof. Varda Shalev and Doron Birger to Board

Pluri Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Varda Shalev

Director
PLUR · Pluri Inc.
Effective
2021-07-15
Filed
July 19, 2021, 7:59 PM ET
On July 15, 2021, the board of directors, or the Board, of Pluristem Therapeutics Inc., or the Company, appointed Prof. Varda Shalev and Mr. Doron Birger to serve as members of the Board, effective immediately,
Appointed

Doron Birger

Director
PLUR · Pluri Inc.
Effective
2021-07-15
Filed
July 19, 2021, 7:59 PM ET
On July 15, 2021, the board of directors, or the Board, of Pluristem Therapeutics Inc., or the Company, appointed Prof. Varda Shalev and Mr. Doron Birger to serve as members of the Board, effective immediately,

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Varda Shalev was appointed as Director at Pluri Inc..

Action
appointed
Role
Director
Exact text from the filing
On July 15, 2021, the board of directors, or the Board, of Pluristem Therapeutics Inc., or the Company, appointed Prof. Varda Shalev and Mr. Doron Birger to serve as members of the Board, effective immediately,
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Doron Birger was appointed as Director at Pluri Inc..

Action
appointed
Role
Director
Exact text from the filing
On July 15, 2021, the board of directors, or the Board, of Pluristem Therapeutics Inc., or the Company, appointed Prof. Varda Shalev and Mr. Doron Birger to serve as members of the Board, effective immediately,
View on SEC.gov

Pluri Inc. filing history →

Source: SEC EDGAR
accession 0001213900-21-037366
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.